Early Detection of Skin Cancer With Sensor Technology

Lawson Health Research Institute

Status: Completed

Conditions: Carcinoma, Basal Cell

Treatments: Device: WR-22 model microwave sensor

Study type: Interventional

Funder types: Other

Identifiers

NCT02668614

HSREB 107218

Details and patient eligibility

About

Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion
• 18 years of age or older

Exclusion criteria

-Poor english fluency, Pregnancy

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

WR-22 model microwave sensor

Experimental group

Treatment:

Device: WR-22 model microwave sensor